{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:45:34Z","timestamp":1776771934686,"version":"3.51.2"},"reference-count":216,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-025-04120-8","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:36:35Z","timestamp":1763480195000},"page":"1516-1548","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Redefining oropharyngeal cancer in the HPV era: integrating precision medicine and immunotherapeutic frontiers"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-4921","authenticated-orcid":false,"given":"Seyed Ebrahim","family":"Alavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lavanya Ajay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasan","family":"Ebrahimi Shahmabadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"8","key":"4120_CR1","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41388-023-02927-9","volume":"43","author":"YX Lim","year":"2024","unstructured":"Lim YX, D\u2019Silva NJ. Hpv-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions. Oncogene. 2024;43(8):543\u201354.","journal-title":"Oncogene"},{"issue":"1","key":"4120_CR2","doi-asserted-by":"publisher","first-page":"6071","DOI":"10.1038\/s41467-020-19822-6","volume":"11","author":"M Gormley","year":"2020","unstructured":"Gormley M, Dudding T, Sanderson E, Martin RM, Thomas S, Tyrrell J, et al. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 2020;11(1):6071.","journal-title":"Nat Commun"},{"issue":"21","key":"4120_CR3","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.3390\/ijerph20217020","volume":"20","author":"R Nikkil\u00e4","year":"2023","unstructured":"Nikkil\u00e4 R, Tolonen S, Salo T, Carp\u00e9n T, Pukkala E, M\u00e4kitie A. Occupational etiology of oropharyngeal cancer: a literature review. Int J Environ Res Public Health. 2023;20(21):7020.","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"4120_CR4","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1016\/j.jds.2024.05.032","volume":"19","author":"AP Pratama","year":"2024","unstructured":"Pratama AP, Chen S-F, Liao S-C, Su W-C, Yu J-H. Incremental net benefit of extending human papillomavirus vaccine to boys in oropharyngeal cancer burden: meta-analysis of cost-effectiveness studies. J Dent Sci. 2024;19(4):2045\u201356.","journal-title":"J Dent Sci"},{"issue":"2","key":"4120_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4103\/ijph.ijph_827_23","volume":"68","author":"HR Singhavi","year":"2024","unstructured":"Singhavi HR, Chaturvedi P, Nair D. The human papillomavirus enigma: a narrative review of global variations in oropharyngeal cancer epidemiology and prognosis. Indian J Public Health. 2024;68(2):268\u201375.","journal-title":"Indian J Public Health"},{"issue":"1","key":"4120_CR6","doi-asserted-by":"publisher","first-page":"3191569","DOI":"10.1155\/2022\/3191569","volume":"2022","author":"M Migliaro","year":"2022","unstructured":"Migliaro M, Massuh D, Infante MF, Brahm AM, San Mart\u00edn MT, Ortu\u00f1o D. Role of Epstein-Barr virus and human papilloma virus in the development of oropharyngeal cancer: a literature review. Int J Dent. 2022;2022(1):3191569.","journal-title":"Int J Dent"},{"issue":"3","key":"4120_CR7","doi-asserted-by":"publisher","first-page":"427","DOI":"10.4067\/S0718-381X2015000300012","volume":"9","author":"W Contreras","year":"2015","unstructured":"Contreras W, Venegas B. Virus papiloma humano en c\u00e1ncer oral y orofar\u00edngeo: revisi\u00f3n de la literatura. Int J Odontostomatol. 2015;9(3):427\u201335.","journal-title":"Int J Odontostomatol"},{"issue":"15","key":"4120_CR8","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/cncr.29992","volume":"122","author":"T Guo","year":"2016","unstructured":"Guo T, Eisele DW, Fakhry C. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer. 2016;122(15):2313\u201323.","journal-title":"Cancer"},{"issue":"4","key":"4120_CR9","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3390\/cancers12040975","volume":"12","author":"F Perri","year":"2020","unstructured":"Perri F, Longo F, Caponigro F, Sandomenico F, Guida A, Della Vittoria Scarpati G, et al. Management of HPV-related squamous cell carcinoma of the head and neck: pitfalls and caveat. Cancers. 2020;12(4):975.","journal-title":"Cancers"},{"issue":"7","key":"4120_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068329","volume":"8","author":"R Herrero","year":"2013","unstructured":"Herrero R, Quint W, Hildesheim A, Gonzalez P, Struijk L, Katki HA, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS ONE. 2013;8(7):e68329. https:\/\/doi.org\/10.1371\/journal.pone.0068329.","journal-title":"PLoS ONE"},{"issue":"1","key":"4120_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1038\/s41467-025-56150-z","volume":"16","author":"N Sasa","year":"2025","unstructured":"Sasa N, Kishikawa T, Mori M, Ito R, Mizoro Y, Suzuki M, et al. Intratumor heterogeneity of HPV integration in HPV-associated head and neck cancer. Nat Commun. 2025;16(1):1052.","journal-title":"Nat Commun"},{"issue":"7","key":"4120_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25074009","volume":"25","author":"IdAF Muniz","year":"2024","unstructured":"Muniz IdAF, Araujo M, Bouassaly J, Farshadi F, Atique M, Esfahani K, et al. Therapeutic advances and challenges for the management of HPV-associated oropharyngeal cancer. Int J Mol Sci. 2024;25(7):4009.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4120_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJMoa0912217","volume":"363","author":"KK Ang","year":"2010","unstructured":"Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-T\u00e2n PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24\u201335.","journal-title":"N Engl J Med"},{"issue":"4","key":"4120_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/jnci\/djn011","volume":"100","author":"C Fakhry","year":"2008","unstructured":"Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus\u2013positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100(4):261\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"4120_CR15","first-page":"93","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population\u2010based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4120_CR16","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1200\/JCO.21.01752","volume":"40","author":"RL Ferris","year":"2022","unstructured":"Ferris RL, Flamand Y, Weinstein GS, Li S, Quon H, Mehra R, et al. Phase II randomized trial of transoral surgery and low-dose intensity modulated radiation therapy in resectable p16+ locally advanced oropharynx cancer: an ECOG-ACRIN cancer research group trial (E3311). J Clin Oncol. 2022;40(2):138\u201349. https:\/\/doi.org\/10.1200\/JCO.21.01752.","journal-title":"J Clin Oncol"},{"issue":"2","key":"4120_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.35287","volume":"131","author":"KJ Contrera","year":"2025","unstructured":"Contrera KJ, Patel MR, Burtness B, Mehra R, Ferris RL. The role of surgery and deescalation for HPV\u2010related oropharyngeal cancer. Cancer. 2025;131(2):e35287. https:\/\/doi.org\/10.1002\/cncr.35287.","journal-title":"Cancer"},{"issue":"10166","key":"4120_CR18","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S0140-6736(18)32779-X","volume":"393","author":"ML Gillison","year":"2019","unstructured":"Gillison ML, Trotti AM, Harris J, Eisbruch A, Harari PM, Adelstein DJ, et al. Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. Lancet. 2019;393(10166):40\u201350. https:\/\/doi.org\/10.1016\/S0140-6736(18)32779-X.","journal-title":"Lancet"},{"key":"4120_CR19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02550","author":"B Burtness","year":"2025","unstructured":"Burtness B, Flamand Y, Quon H, Weinstein GS, Mehra R, Garcia JJ, et al. Long-term follow-up of E3311, an ECOG-ACRIN cancer research group phase II trial of transoral surgery and risk-based adjuvant treatment in human papillomavirus\u2013initiated oropharynx cancer. J Clin Oncol. 2025. https:\/\/doi.org\/10.1200\/JCO-24-02550.","journal-title":"J Clin Oncol"},{"key":"4120_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/ohn.1261","author":"T Tharakan","year":"2025","unstructured":"Tharakan T, Puram SV, Paniello RC, Pipkorn P, Zolkind P, Harbison RA, et al. Patient\u2010reported swallowing outcomes in HPV+ oropharyngeal cancer by postoperative chemoradiation dose in MINT and E3311. Otolaryngol Head Neck Surg. 2025. https:\/\/doi.org\/10.1002\/ohn.1261.","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"8","key":"4120_CR21","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1200\/JCO.21.01961","volume":"40","author":"AC Nichols","year":"2022","unstructured":"Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, et al. Randomized trial of radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: long-term results of the ORATOR trial. J Clin Oncol. 2022;40(8):866\u201375.","journal-title":"J Clin Oncol"},{"key":"4120_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115343","volume":"220","author":"DA Palma","year":"2025","unstructured":"Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, et al. Radiation vs. trans-oral surgery for treatment de-escalation in HPV-related oropharyngeal cancers: primary analysis of the ORATOR2 randomized trial. Eur J Cancer. 2025;220:115343.","journal-title":"Eur J Cancer"},{"issue":"34","key":"4120_CR23","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1200\/JCO.24.00119","volume":"42","author":"AC Nichols","year":"2024","unstructured":"Nichols AC, Theurer J, Prisman E, Read N, Berthelet E, Tran E, et al. Radiotherapy versus transoral robotic surgery for oropharyngeal squamous cell carcinoma: final results of the ORATOR randomized trial. J Clin Oncol. 2024;42(34):4023\u20138.","journal-title":"J Clin Oncol"},{"issue":"6","key":"4120_CR24","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1001\/jamaoncol.2022.0615","volume":"8","author":"DA Palma","year":"2022","unstructured":"Palma DA, Prisman E, Berthelet E, Tran E, Hamilton S, Wu J, et al. Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma: the ORATOR2 phase 2 randomized clinical trial. JAMA Oncol. 2022;8(6):845\u201351.","journal-title":"JAMA Oncol"},{"issue":"10166","key":"4120_CR25","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","volume":"393","author":"H Mehanna","year":"2019","unstructured":"Mehanna H, Robinson M, Hartley A, Kong A, Foran B, Fulton-Lieuw T, et al. Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet. 2019;393(10166):51\u201360.","journal-title":"Lancet"},{"key":"4120_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejca.2019.10.025","volume":"124","author":"DA Jones","year":"2020","unstructured":"Jones DA, Mistry P, Dalby M, Fulton-Lieuw T, Kong AH, Dunn J, et al. Concurrent cisplatin or cetuximab with radiotherapy for HPV-positive oropharyngeal cancer: medical resource use, costs, and quality-adjusted survival from the De-ESCALaTE HPV trial. Eur J Cancer. 2020;124:178\u201385. https:\/\/doi.org\/10.1016\/j.ejca.2019.10.025.","journal-title":"Eur J Cancer"},{"issue":"9","key":"4120_CR27","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s00405-020-05979-9","volume":"277","author":"P Machczy\u0144ski","year":"2020","unstructured":"Machczy\u0144ski P, Majchrzak E, Niewinski P, Marchlewska J, Golusi\u0144ski W. A review of the 8th edition of the AJCC staging system for oropharyngeal cancer according to HPV status. Eur Arch Otorhinolaryngol. 2020;277(9):2407\u201312.","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"12","key":"4120_CR28","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1007\/s00405-018-5156-4","volume":"275","author":"SJ Sharma","year":"2018","unstructured":"Sharma SJ, Wagner S, Reder HSF, Kroll T, Wuerdemann N, Klussmann JP, et al. The 8th edition AJCC\/UICC TNM staging for p16-positive oropharyngeal carcinoma: is there space for improvement? Eur Arch Otorhinolaryngol. 2018;275(12):3087\u201391.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4120_CR29","unstructured":"Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual: Berlin: Springer; 2017."},{"issue":"15","key":"4120_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21155228","volume":"21","author":"N Wuerdemann","year":"2020","unstructured":"Wuerdemann N, G\u00fcltekin SE, P\u00fctz K, Wittekindt C, Huebbers CU, Sharma SJ, et al. PD-L1 expression and a high tumor infiltrate of CD8+ lymphocytes predict outcome in patients with oropharyngeal squamous cells carcinoma. Int J Mol Sci. 2020;21(15):5228. https:\/\/doi.org\/10.3390\/ijms21155228.","journal-title":"Int J Mol Sci"},{"issue":"10212","key":"4120_CR31","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness B, Harrington KJ, Greil R, Souli\u00e8res D, Tahara M, de Castro G, et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet. 2019;394(10212):1915\u201328. https:\/\/doi.org\/10.1016\/S0140-6736(19)32591-7.","journal-title":"Lancet"},{"issue":"4","key":"4120_CR32","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1200\/JCO.21.02508","volume":"41","author":"KJ Harrington","year":"2023","unstructured":"Harrington KJ, Burtness B, Greil R, Souli\u00e8res D, Tahara M, de Castro GJr, et al. Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: updated results of the phase III KEYNOTE-048 study. J Clin Oncol. 2023;41(4):790\u2013802.","journal-title":"J Clin Oncol"},{"key":"4120_CR33","unstructured":"IARC. GCO. Cancer TODAY. Globocan. 2025. https:\/\/gco.iarc.fr\/today\/en\/dataviz\/bars?mode=cancer&group_populations=1&multiple_populations=1. Accessed 26 May 2025."},{"key":"4120_CR34","doi-asserted-by":"crossref","unstructured":"Chan KS-K, Mak TST, Yu OY, Lee VHF, Chu CH, Chan SCS, et al. HPV vaccine communication and administration for the prevention of oropharyngeal cancer in dental primary care: perspectives of professionals and students\u2014a systematic review. Vaccines. 2025;13(3):242.","DOI":"10.3390\/vaccines13030242"},{"issue":"3","key":"4120_CR35","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"10258","key":"4120_CR36","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"T Vos","year":"2020","unstructured":"Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1204\u201322.","journal-title":"Lancet"},{"issue":"30","key":"4120_CR37","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1200\/JCO.2014.55.1937","volume":"32","author":"C Fakhry","year":"2014","unstructured":"Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, et al. Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol. 2014;32(30):3365\u201373.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4120_CR38","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/jamaoto.2015.136","volume":"141","author":"SJ Trosman","year":"2015","unstructured":"Trosman SJ, Koyfman SA, Ward MC, Al-Khudari S, Nwizu T, Greskovich JF, et al. Effect of human papillomavirus on patterns of distant metastatic failure in oropharyngeal squamous cell carcinoma treated with chemoradiotherapy. JAMA Otolaryngol Head Neck Surg. 2015;141(5):457\u201362.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"15","key":"4120_CR39","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.3390\/jcm13154455","volume":"13","author":"J Chen","year":"2024","unstructured":"Chen J, Zhang X, Yan S, Li X, Li M, Zhang Y, et al. Transoral robotic surgery and human papillomavirus infection: impact on oropharyngeal cancer prognosis. J Clin Med. 2024;13(15):4455.","journal-title":"J Clin Med"},{"issue":"4","key":"4120_CR40","doi-asserted-by":"publisher","first-page":"801","DOI":"10.26574\/maedica.2024.19.4.801","volume":"19","author":"E Kokkinis","year":"2024","unstructured":"Kokkinis E, Bastas NS, Mega I, Tsironis C, Lianou AD. Association of HPV with oral and oropharyngeal cancer: current evidence. Maedica. 2024;19(4):801\u20136. https:\/\/doi.org\/10.26574\/maedica.2024.19.4.801.","journal-title":"Maedica"},{"issue":"7","key":"4120_CR41","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/v13071326","volume":"13","author":"AF Carlander","year":"2021","unstructured":"Carlander AF, Jakobsen KK, Bendtsen SK, Garset-Zamani M, Lynggaard CD, Jensen JS, et al. A contemporary systematic review on repartition of HPV-positivity in oropharyngeal cancer worldwide. Viruses. 2021;13(7):1326.","journal-title":"Viruses"},{"issue":"5","key":"4120_CR42","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/hed.22015","volume":"35","author":"H Mehanna","year":"2013","unstructured":"Mehanna H, Beech T, Nicholson T, El-Hariry I, McConkey C, Paleri V, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer\u2014systematic review and meta-analysis of trends by time and region. Head Neck. 2013;35(5):747\u201355.","journal-title":"Head Neck"},{"key":"4120_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/biom14080925","author":"A Krsek","year":"2024","unstructured":"Krsek A, Baticic L, Braut T, Sotosek V. The next chapter in cancer diagnostics: advances in HPV-positive head and neck cancer. Biomolecules. 2024. https:\/\/doi.org\/10.3390\/biom14080925.","journal-title":"Biomolecules"},{"issue":"7","key":"4120_CR44","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.joms.2022.03.015","volume":"80","author":"J Cheng","year":"2022","unstructured":"Cheng J, Zhou X, Xu H, Dan H, Li J, Chen Q. Incidence and survival of oral cavity and oropharyngeal cancer in the United States from 1975 to 2018. J Oral Maxillofac Surg. 2022;80(7):1294\u2013305.","journal-title":"J Oral Maxillofac Surg"},{"issue":"2","key":"4120_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28448","volume":"95","author":"S Baliga","year":"2023","unstructured":"Baliga S, Mitchell D, Yildiz VO, Gogineni E, Konieczkowski DJ, Grecula J, et al. Disparities in survival outcomes among Black patients with HPV\u2010associated oropharyngeal cancer. J Med Virol. 2023;95(2):e28448. https:\/\/doi.org\/10.1002\/jmv.28448.","journal-title":"J Med Virol"},{"key":"4120_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.105832","volume":"128","author":"CD de la Cour","year":"2022","unstructured":"de la Cour CD, Munk C, Aalborg GL, Kjaer SK. Base of tongue\/tonsillar and laryngeal cancer in Denmark 1994\u20132018: temporal trends in incidence according to education and age. Oral Oncol. 2022;128:105832. https:\/\/doi.org\/10.1016\/j.oraloncology.2022.105832.","journal-title":"Oral Oncol"},{"issue":"1","key":"4120_CR47","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00439-007-0448-6","volume":"123","author":"S Ebrahim","year":"2008","unstructured":"Ebrahim S, Davey Smith G. Mendelian randomization: can genetic epidemiology help redress the failures of observational epidemiology? Hum Genet. 2008;123(1):15\u201333. https:\/\/doi.org\/10.1007\/s00439-007-0448-6.","journal-title":"Hum Genet"},{"issue":"2","key":"4120_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0022034519894963","volume":"99","author":"M Du","year":"2020","unstructured":"Du M, Nair R, Jamieson L, Liu Z, Bi P. Incidence trends of lip, oral cavity, and pharyngeal cancers: global burden of disease 1990\u20132017. J Dent Res. 2020;99(2):143\u201351. https:\/\/doi.org\/10.1177\/0022034519894963.","journal-title":"J Dent Res"},{"key":"4120_CR49","doi-asserted-by":"crossref","unstructured":"Paric A, Tomic K, Alidzanovic L, Fojnica A, Vranic S. HPV-related cancers in bosnia and herzegovina: a comprehensive review. Acta Medica Academica. 2024;53(3):237-273. https:\/\/doi.org\/10.5644\/ama2006-124.458.","DOI":"10.5644\/ama2006-124.458"},{"issue":"10","key":"4120_CR50","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1001\/jamaoncol.2023.2960","volume":"9","author":"AR Da Cunha","year":"2023","unstructured":"Da Cunha AR, Compton K, Xu R, Mishra R, Drangsholt MT, Antunes JLF, et al. The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2023;9(10):1401\u201316.","journal-title":"JAMA Oncol"},{"issue":"7","key":"4120_CR51","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1111\/jop.12907","volume":"48","author":"K Pollaers","year":"2019","unstructured":"Pollaers K, Massingham I, Friedland PL, Farah CS. The economic burden of oral squamous cell carcinoma in Australia. J Oral Pathol Med. 2019;48(7):588\u201394.","journal-title":"J Oral Pathol Med"},{"issue":"9","key":"4120_CR52","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1158\/1055-9965.EPI-17-0220","volume":"26","author":"DR Lairson","year":"2017","unstructured":"Lairson DR, Wu C-F, Chan W, Dahlstrom KR, Tam S, Sturgis EM. Medical care cost of oropharyngeal cancer among Texas patients. Cancer Epidemiol Biomarkers Prev. 2017;26(9):1443\u20139.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4120_CR53","first-page":"4103","volume":"10","author":"SK Swain","year":"2025","unstructured":"Swain SK. Biomarkers in head-and-neck cancer: a scoping review. Mustansiriya Med J. 2025;10:4103.","journal-title":"Mustansiriya Med J."},{"issue":"4","key":"4120_CR54","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ijrobp.2020.04.011","volume":"107","author":"D Lin","year":"2020","unstructured":"Lin D, Lapen K, Sherer MV, Kantor J, Zhang Z, Boyce LM, et al. A systematic review of contouring guidelines in radiation oncology: analysis of frequency, methodology, and delivery of consensus recommendations. Int J Radiat Oncol Biol Phys. 2020;107(4):827\u201335.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"4120_CR55","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1016\/j.oraloncology.2015.10.011","volume":"51","author":"RP Takes","year":"2015","unstructured":"Takes RP, Wierzbicka M, D\u2019Souza G, Jackowska J, Silver CE, Rodrigo JP, et al. HPV vaccination to prevent oropharyngeal carcinoma: what can be learned from anogenital vaccination programs? Oral Oncol. 2015;51(12):1057\u201360.","journal-title":"Oral Oncol"},{"issue":"3","key":"4120_CR56","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-026286","volume":"147","author":"K Sonawane","year":"2021","unstructured":"Sonawane K, Zhu Y, Lin Y-Y, Damgacioglu H, Lin Y, Montealegre JR, et al. HPV vaccine recommendations and parental intent. Pediatrics. 2021;147(3):e2020026286. https:\/\/doi.org\/10.1542\/peds.2020-026286.","journal-title":"Pediatrics"},{"issue":"3","key":"4120_CR57","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1200\/JCO.2017.75.0141","volume":"36","author":"AK Chaturvedi","year":"2018","unstructured":"Chaturvedi AK, Graubard BI, Broutian T, Pickard RK, Tong Z-Y, Xiao W, et al. Effect of prophylactic human papillomavirus (HPV) vaccination on oral HPV infections among young adults in the United States. J Clin Oncol. 2018;36(3):262\u20137.","journal-title":"J Clin Oncol"},{"key":"4120_CR58","doi-asserted-by":"publisher","first-page":"1150238","DOI":"10.3389\/fimmu.2023.1150238","volume":"14","author":"N Ebrahimi","year":"2023","unstructured":"Ebrahimi N, Yousefi Z, Khosravi G, Malayeri FE, Golabi M, Askarzadeh M, et al. Human papillomavirus vaccination in low-and middle-income countries: progression, barriers, and future prospective. Front Immunol. 2023;14:1150238.","journal-title":"Front Immunol"},{"key":"4120_CR59","unstructured":"Mataruse EC, Corwin AL. Optimizing and applying lessons learnt from Rwanda\u2019s HPV vaccination program to Zimbabwe: Thammasat University; 2023."},{"key":"4120_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2020.106399","volume":"144","author":"L Bruni","year":"2021","unstructured":"Bruni L, Saura-L\u00e1zaro A, Montoliu A, Brotons M, Alemany L, Diallo MS, et al. HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019. Prev Med. 2021;144:106399. https:\/\/doi.org\/10.1016\/j.ypmed.2020.106399.","journal-title":"Prev Med"},{"key":"4120_CR61","doi-asserted-by":"publisher","first-page":"1380663","DOI":"10.3389\/fonc.2024.1380663","volume":"14","author":"A Ewongwo","year":"2024","unstructured":"Ewongwo A, Sahor AF, Ngwa W, Nwachukwu C. A guide to global access to HPV vaccination to all women in low-and middle-income countries; a minireview of innovation and equity. Front Oncol. 2024;14:1380663.","journal-title":"Front Oncol"},{"issue":"8","key":"4120_CR62","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s10147-023-02336-8","volume":"28","author":"H Shinomiya","year":"2023","unstructured":"Shinomiya H, Nibu K-i. Etiology, diagnosis, treatment, and prevention of human papilloma virus-associated oropharyngeal squamous cell carcinoma. Int J Clin Oncol. 2023;28(8):975\u201381.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"4120_CR63","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13027-022-00479-3","volume":"18","author":"P Macilwraith","year":"2023","unstructured":"Macilwraith P, Malsem E, Dushyanthen S. The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review. Infect Agents Cancer. 2023;18(1):24.","journal-title":"Infect Agents Cancer"},{"issue":"1","key":"4120_CR64","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/jamaoncol.2018.4051","volume":"5","author":"E Massarelli","year":"2019","unstructured":"Massarelli E, William W, Johnson F, Kies M, Ferrarotto R, Guo M, et al. Combining immune checkpoint blockade and tumor-specific vaccine for patients with incurable human papillomavirus 16-related cancer: a phase 2 clinical trial. JAMA Oncol. 2019;5(1):67\u201373.","journal-title":"JAMA Oncol"},{"key":"4120_CR65","doi-asserted-by":"crossref","unstructured":"Solomon B, Young RJ, Rischin D, editors. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments. Seminars in cancer biology. Elsevier; 2018.","DOI":"10.1016\/j.semcancer.2018.01.008"},{"issue":"5","key":"4120_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051060","volume":"12","author":"JR Lechien","year":"2020","unstructured":"Lechien JR, Descamps G, Seminerio I, Furgiuele S, Dequanter D, Mouawad F, et al. HPV involvement in the tumor microenvironment and immune treatment in head and neck squamous cell carcinomas. Cancers. 2020;12(5):1060. https:\/\/doi.org\/10.3390\/cancers12051060.","journal-title":"Cancers"},{"key":"4120_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-020-00938-3","volume":"22","author":"NE Wondergem","year":"2020","unstructured":"Wondergem NE, Nauta IH, Muijlwijk T, Leemans CR, van de Ven R. The immune microenvironment in head and neck squamous cell carcinoma: on subsets and subsites. Curr Oncol Rep. 2020;22:1\u201314.","journal-title":"Curr Oncol Rep"},{"key":"4120_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00052","volume":"7","author":"M Canning","year":"2019","unstructured":"Canning M, Guo G, Yu M, Myint C, Groves MW, Byrd JK, et al. Heterogeneity of the head and neck squamous cell carcinoma immune landscape and its impact on immunotherapy. Front Cell Dev Biol. 2019;7:52. https:\/\/doi.org\/10.3389\/fcell.2019.00052.","journal-title":"Front Cell Dev Biol"},{"key":"4120_CR69","doi-asserted-by":"crossref","unstructured":"Cillo AR, K\u00fcrten CH, Tabib T, Qi Z, Onkar S, Wang T, et al. Immune landscape of viral-and carcinogen-driven head and neck cancer. Immunity. 2020;52(1):183\u201399. e9.","DOI":"10.1016\/j.immuni.2019.11.014"},{"issue":"1","key":"4120_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27619-4","volume":"12","author":"CH K\u00fcrten","year":"2021","unstructured":"K\u00fcrten CH, Kulkarni A, Cillo AR, Santos PM, Roble AK, Onkar S, et al. Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing. Nat Commun. 2021;12(1):7338. https:\/\/doi.org\/10.1038\/s41467-021-27619-4.","journal-title":"Nat Commun"},{"key":"4120_CR71","doi-asserted-by":"publisher","first-page":"1087843","DOI":"10.3389\/fimmu.2022.1087843","volume":"13","author":"DG Jimenez","year":"2023","unstructured":"Jimenez DG, Altunbulakli C, Swoboda S, Sobti A, Askmyr D, Ali A, et al. Single-cell analysis of myeloid cells in HPV+ tonsillar cancer. Front Immunol. 2023;13:1087843.","journal-title":"Front Immunol"},{"issue":"9","key":"4120_CR72","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1158\/1078-0432.CCR-21-1130","volume":"28","author":"M Lauss","year":"2022","unstructured":"Lauss M, Donia M, Svane IM, J\u00f6nsson G. B cells and tertiary lymphoid structures: friends or foes in cancer immunotherapy? Clin Cancer Res. 2022;28(9):1751\u20138.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4120_CR73","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1038\/s41467-021-23355-x","volume":"12","author":"AT Ruffin","year":"2021","unstructured":"Ruffin AT, Cillo AR, Tabib T, Liu A, Onkar S, Kunning SR, et al. B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma. Nat Commun. 2021;12(1):3349.","journal-title":"Nat Commun"},{"issue":"12","key":"4120_CR74","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/ni.3290","volume":"16","author":"S Finkin","year":"2015","unstructured":"Finkin S, Yuan D, Stein I, Taniguchi K, Weber A, Unger K, et al. Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma. Nat Immunol. 2015;16(12):1235\u201344.","journal-title":"Nat Immunol"},{"key":"4120_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2025.107605","volume":"168","author":"S Xu","year":"2025","unstructured":"Xu S, Lv Y, He H, Han C, Zhou J, Yang D, et al. Immune stratification in HPV-negative HNSCC: prognostic significance and prediction of immunotherapy response. Oral Oncol. 2025;168:107605. https:\/\/doi.org\/10.1016\/j.oraloncology.2025.107605.","journal-title":"Oral Oncol"},{"key":"4120_CR76","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200389","author":"KH Bhatt","year":"2020","unstructured":"Bhatt KH, Neller MA, Srihari S, Crooks P, Lekieffre L, Aftab BT, et al. Profiling HPV-16-specific T cell responses reveals broad antigen reactivities in oropharyngeal cancer patients. J Exp Med. 2020. https:\/\/doi.org\/10.1084\/jem.20200389.","journal-title":"J Exp Med"},{"issue":"7875","key":"4120_CR77","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-020-2931-3","volume":"597","author":"A Wieland","year":"2021","unstructured":"Wieland A, Patel MR, Cardenas MA, Eberhardt CS, Hudson WH, Obeng RC, et al. Defining HPV-specific B cell responses in patients with head and neck cancer. Nature. 2021;597(7875):274\u20138.","journal-title":"Nature"},{"issue":"1","key":"4120_CR78","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s44337-025-00266-0","volume":"2","author":"D Mathevosyan","year":"2025","unstructured":"Mathevosyan D, Avetisyan G, Hakobyan G. Advanced diagnostic methods in oral and maxillofacial malignant neoplasms. Discover Med. 2025;2(1):84.","journal-title":"Discover Med"},{"issue":"2","key":"4120_CR79","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/biomedicines12020415","volume":"12","author":"HW Eberly","year":"2024","unstructured":"Eberly HW, Sciscent BY, Lorenz FJ, Rettig EM, Goyal N. Current and emerging diagnostic, prognostic, and predictive biomarkers in head and neck cancer. Biomedicines. 2024;12(2):415.","journal-title":"Biomedicines"},{"key":"4120_CR80","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2025.0848","author":"SH Huang","year":"2025","unstructured":"Huang SH, Su J, Koyfman SA, Routman D, Hoebers F, Bahig H, et al. A proposal for HPV-associated oropharyngeal carcinoma in the ninth edition clinical TNM classification. JAMA Otolaryngology\u2013Head & Neck Surgery. 2025. https:\/\/doi.org\/10.1001\/jamaoto.2025.0848.","journal-title":"JAMA Otolaryngology\u2013Head & Neck Surgery"},{"issue":"5","key":"4120_CR81","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00262-016-1819-4","volume":"65","author":"PM van Kempen","year":"2016","unstructured":"van Kempen PM, Noorlag R, Swartz JE, Bovenschen N, Braunius WW, Vermeulen JF, et al. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors. Cancer Immunol Immunother. 2016;65(5):575\u201385.","journal-title":"Cancer Immunol Immunother"},{"issue":"7","key":"4120_CR82","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3390\/cancers13071714","volume":"13","author":"SJ De Keukeleire","year":"2021","unstructured":"De Keukeleire SJ, Vermassen T, Hilgert E, Creytens D, Ferdinande L, Rottey S. Immuno-oncological biomarkers for squamous cell cancer of the head and neck: current state of the art and future perspectives. Cancers. 2021;13(7):1714.","journal-title":"Cancers"},{"issue":"3","key":"4120_CR83","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S1470-2045(23)00013-X","volume":"24","author":"H Mehanna","year":"2023","unstructured":"Mehanna H, Taberna M, von Buchwald C, Tous S, Brooks J, Mena M, et al. Prognostic implications of p16 and HPV discordance in oropharyngeal cancer (HNCIG-EPIC-OPC): a multicentre, multinational, individual patient data analysis. Lancet Oncol. 2023;24(3):239\u201351.","journal-title":"Lancet Oncol"},{"key":"4120_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106644","volume":"148","author":"RF Shenker","year":"2024","unstructured":"Shenker RF, Razavian NB, D\u2019Agostino JRB, Mowery YM, Brizel DM, Hughes RT. Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: a systematic review and meta-analysis. Oral Oncol. 2024;148:106644.","journal-title":"Oral Oncol"},{"key":"4120_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106417","volume":"141","author":"EM Rettig","year":"2023","unstructured":"Rettig EM, Waterboer T, Sim E, Faden DL, Butt J, Hanna GJ, et al. Relationship of HPV16 E6 seropositivity with circulating tumor tissue modified HPV16 DNA before head and neck cancer diagnosis. Oral Oncol. 2023;141:106417. https:\/\/doi.org\/10.1016\/j.oraloncology.2023.106417.","journal-title":"Oral Oncol"},{"issue":"8","key":"4120_CR86","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/annonc\/mdz138","volume":"30","author":"AR Kreimer","year":"2019","unstructured":"Kreimer AR, Ferreiro-Iglesias A, Nygard M, Bender N, Schroeder L, Hildesheim A, et al. Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium. Ann Oncol. 2019;30(8):1335\u201343. https:\/\/doi.org\/10.1093\/annonc\/mdz138.","journal-title":"Ann Oncol"},{"issue":"12","key":"4120_CR87","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/ijc.30697","volume":"140","author":"D Holzinger","year":"2017","unstructured":"Holzinger D, Wichmann G, Baboci L, Michel A, H\u00f6fler D, Wiesenfarth M, et al. Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma. Int J Cancer. 2017;140(12):2748\u201357. https:\/\/doi.org\/10.1002\/ijc.30697.","journal-title":"Int J Cancer"},{"issue":"11","key":"4120_CR88","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1001\/jamaoto.2023.1937","volume":"149","author":"RM Ferrandino","year":"2023","unstructured":"Ferrandino RM, Chen S, Kappauf C, Barlow J, Gold BS, Berger MH, et al. Performance of liquid biopsy for diagnosis and surveillance of human papillomavirus-associated oropharyngeal cancer. JAMA Otolaryngol\u2013Head Neck Surg. 2023;149(11):971\u20137. https:\/\/doi.org\/10.1001\/jamaoto.2023.1937.","journal-title":"JAMA Otolaryngol\u2013Head Neck Surg"},{"issue":"19","key":"4120_CR89","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1158\/1078-0432.CCR-22-0562","volume":"28","author":"BM Berger","year":"2022","unstructured":"Berger BM, Hanna GJ, Posner MR, Genden EM, Lautersztain J, Naber SP, et al. Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma. Clin Cancer Res. 2022;28(19):4292\u2013301. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0562.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"4120_CR90","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/j.ejso.2022.03.232","volume":"48","author":"SJ Warlow","year":"2022","unstructured":"Warlow SJ, Adamowicz M, Thomson JP, Wescott RA, Robert C, Carey LM, et al. Longitudinal measurement of HPV copy number in cell-free DNA is associated with patient outcomes in HPV-positive oropharyngeal cancer. Eur J Surg Oncol. 2022;48(6):1224\u201334. https:\/\/doi.org\/10.1016\/j.ejso.2022.03.232.","journal-title":"Eur J Surg Oncol"},{"issue":"11","key":"4120_CR91","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/cncr.34109","volume":"128","author":"CJ O'Boyle","year":"2022","unstructured":"O\u2019Boyle CJ, Siravegna G, Varmeh S, Queenan N, Michel A, Pang KCS, et al. Cell-free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer. Cancer. 2022;128(11):2193\u2013204.","journal-title":"Cancer"},{"issue":"1","key":"4120_CR92","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1186\/s12885-024-12125-9","volume":"24","author":"F Deutsch","year":"2024","unstructured":"Deutsch F, Sais D, Keatinge N, Hill M, Tran NH, Elliott M, et al. Biplex quantitative PCR to detect transcriptionally active human papillomavirus 16 from patient saliva. BMC Cancer. 2024;24(1):442.","journal-title":"BMC Cancer"},{"issue":"3","key":"4120_CR93","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ijrobp.2022.02.012","volume":"113","author":"DM Routman","year":"2022","unstructured":"Routman DM, Kumar S, Chera BS, Jethwa KR, Van Abel KM, Frechette K, et al. Detectable postoperative circulating tumor human papillomavirus DNA and association with recurrence in patients with HPV-associated oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2022;113(3):530\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"4120_CR94","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1200\/JCO.19.02444","volume":"38","author":"BS Chera","year":"2020","unstructured":"Chera BS, Kumar S, Shen C, Amdur R, Dagan R, Green R, et al. Plasma circulating tumor HPV DNA for the surveillance of cancer recurrence in HPV-associated oropharyngeal cancer. J Clin Oncol. 2020;38(10):1050\u20138.","journal-title":"J Clin Oncol"},{"issue":"20","key":"4120_CR95","doi-asserted-by":"publisher","first-page":"4306","DOI":"10.1158\/1078-0432.CCR-23-1478","volume":"29","author":"GJ Hanna","year":"2023","unstructured":"Hanna GJ, Roof SA, Jabalee J, Rettig EM, Ferrandino R, Chen S, et al. Negative predictive value of circulating tumor tissue modified viral (TTMV)-HPV DNA for HPV-driven oropharyngeal cancer surveillance. Clin Cancer Res. 2023;29(20):4306\u201313.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"4120_CR96","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/CCO.0000000000000935","volume":"35","author":"I Tinhofer","year":"2023","unstructured":"Tinhofer I, Staudte S, George S. Liquid biopsy in head neck cancer: ready for clinical routine diagnostics? Curr Opin Oncol. 2023;35(3):151\u20137.","journal-title":"Curr Opin Oncol"},{"issue":"19","key":"4120_CR97","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1158\/1078-0432.CCR-22-0562","volume":"28","author":"BM Berger","year":"2022","unstructured":"Berger BM, Hanna GJ, Posner MR, Genden EM, Lautersztain J, Naber SP, et al. Detection of occult recurrence using circulating tumor tissue modified viral HPV DNA among patients treated for HPV-driven oropharyngeal carcinoma. Clin Cancer Res. 2022;28(19):4292\u2013301.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4120_CR98","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3343\/alm.2022.42.2.141","volume":"42","author":"S Shin","year":"2022","unstructured":"Shin S, Woo HI, Kim J-W, Kim Y, Lee K-A. Clinical practice guidelines for pre-analytical procedures of plasma epidermal growth factor receptor variant testing. Ann Lab Med. 2022;42(2):141\u20139.","journal-title":"Ann Lab Med"},{"issue":"1","key":"4120_CR99","doi-asserted-by":"publisher","first-page":"7375","DOI":"10.1038\/s41598-018-25810-0","volume":"8","author":"H Markus","year":"2018","unstructured":"Markus H, Contente-Cuomo T, Farooq M, Liang WS, Borad MJ, Sivakumar S, et al. Evaluation of pre-analytical factors affecting plasma DNA analysis. Sci Rep. 2018;8(1):7375.","journal-title":"Sci Rep"},{"issue":"1","key":"4120_CR100","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/clinchem\/hvad194","volume":"70","author":"P Van Der Leest","year":"2024","unstructured":"Van Der Leest P, Schuuring E. Critical factors in the analytical work flow of circulating tumor DNA-based molecular profiling. Clin Chem. 2024;70(1):220\u201333.","journal-title":"Clin Chem"},{"issue":"11","key":"4120_CR101","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1002\/cncr.34109","volume":"128","author":"CJ O'Boyle","year":"2022","unstructured":"O\u2019Boyle CJ, Siravegna G, Varmeh S, Queenan N, Michel A, Pang KCS, et al. Cell\u2010free human papillomavirus DNA kinetics after surgery for human papillomavirus-associated oropharyngeal cancer. Cancer. 2022;128(11):2193\u2013204. https:\/\/doi.org\/10.1002\/cncr.34109.","journal-title":"Cancer"},{"key":"4120_CR102","doi-asserted-by":"publisher","DOI":"10.1200\/PO.22.00494","volume":"7","author":"H Tanaka","year":"2023","unstructured":"Tanaka H, Uno A, Takenaka Y, Suzuki M, Seo Y, Takemoto N, et al. Clearance profile of circulating tumor human papillomavirus DNA during radiotherapy predicts clinical outcomes in human papillomavirus-related oropharyngeal cancer. JCO Precis Oncol. 2023;7:e2200494.","journal-title":"JCO Precis Oncol"},{"key":"4120_CR103","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-25-0152","author":"AJ Rosenberg","year":"2025","unstructured":"Rosenberg AJ, Izumchenko E, Juloori A, Katipally R, Cursio J, Choudhury N, et al. Early dynamics of circulating tumor HPV-DNA with neoadjuvant chemotherapy and response-adapted de-escalation in human papillomavirus-associated oropharyngeal cancer. Clin Cancer Res. 2025. https:\/\/doi.org\/10.1158\/1078-0432.CCR-25-0152.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"4120_CR104","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1158\/1078-0432.CCR-24-3053","volume":"31","author":"EM Rettig","year":"2025","unstructured":"Rettig EM, Schoenfeld JD, Miller J, Sargent B, Carey E, Margalit DN, et al. A prospective trial of biomarker-guided surveillance for HPV-positive oropharynx cancer using plasma tumor tissue-modified viral HPV DNA. Clin Cancer Res. 2025;31(9):1605\u201314. https:\/\/doi.org\/10.1158\/1078-0432.CCR-24-3053.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4120_CR105","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jamaoto.2014.141","volume":"140","author":"WR McIlwain","year":"2014","unstructured":"McIlwain WR, Sood AJ, Nguyen SA, Day TA. Initial symptoms in patients with HPV-positive and HPV-negative oropharyngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(5):441\u20137. https:\/\/doi.org\/10.1001\/jamaoto.2014.141.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"4","key":"4120_CR106","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/S1470-2045(15)00560-4","volume":"17","author":"B O'Sullivan","year":"2016","unstructured":"O\u2019Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17(4):440\u201351. https:\/\/doi.org\/10.1016\/S1470-2045(15)00560-4.","journal-title":"Lancet Oncol"},{"issue":"12","key":"4120_CR107","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187992","volume":"12","author":"H Shinomiya","year":"2017","unstructured":"Shinomiya H, Shinomiya H, Kubo M, Saito Y, Yoshida M, Ando M, et al. Prognostic value of ALDH2 polymorphism for patients with oropharyngeal cancer in a Japanese population. PLoS ONE. 2017;12(12):e0187992. https:\/\/doi.org\/10.1371\/journal.pone.0187992.","journal-title":"PLoS ONE"},{"issue":"11","key":"4120_CR108","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1002\/cncr.28015","volume":"119","author":"Y Saito","year":"2013","unstructured":"Saito Y, Yoshida M, Ushiku T, Omura G, Ebihara Y, Shimono T, et al. Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer. 2013;119(11):2005\u201311. https:\/\/doi.org\/10.1002\/cncr.28015.","journal-title":"Cancer"},{"issue":"10","key":"4120_CR109","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-6264","volume":"9","author":"CS Farah","year":"2021","unstructured":"Farah CS. Molecular landscape of head and neck cancer and implications for therapy. Ann Transl Med. 2021;9(10):915. https:\/\/doi.org\/10.21037\/atm-20-6264.","journal-title":"Ann Transl Med"},{"issue":"10","key":"4120_CR110","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1182\/blood.V99.10.3530","volume":"99","author":"CL Sawyers","year":"2002","unstructured":"Sawyers CL, Hochhaus A, Feldman E, Goldman JM, Miller CB, Ottmann OG, et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study: presented in part at the 43rd Annual Meeting of The American Society of Hematology, Orlando, FL, December 11, 2001. Blood. 2002;99(10):3530\u20139.","journal-title":"Blood"},{"key":"4120_CR111","doi-asserted-by":"publisher","first-page":"117955491877958","DOI":"10.1177\/1179554918779581","volume":"12","author":"E Malone","year":"2018","unstructured":"Malone E, Siu LL. Precision medicine in head and neck cancer: myth or reality? Clin Med Insights Oncol. 2018;12:1179554918779581.","journal-title":"Clin Med Insights Oncol"},{"issue":"4","key":"4120_CR112","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.molcel.2015.05.005","volume":"58","author":"Y Wang","year":"2015","unstructured":"Wang Y, Navin NE. Advances and applications of single-cell sequencing technologies. Mol Cell. 2015;58(4):598\u2013609.","journal-title":"Mol Cell"},{"issue":"9","key":"4120_CR113","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","volume":"18","author":"SM Lewis","year":"2021","unstructured":"Lewis SM, Asselin-Labat M-L, Nguyen Q, Berthelet J, Tan X, Wimmer VC, et al. Spatial omics and multiplexed imaging to explore cancer biology. Nat Methods. 2021;18(9):997\u20131012.","journal-title":"Nat Methods"},{"issue":"15","key":"4120_CR114","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.3390\/cancers15153894","volume":"15","author":"S Pillai","year":"2023","unstructured":"Pillai S, Kwan JC, Yaziji F, Yu H, Tran SD. Mapping the potential of microfluidics in early diagnosis and personalized treatment of head and neck cancers. Cancers. 2023;15(15):3894.","journal-title":"Cancers"},{"issue":"179","key":"4120_CR115","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3005616","volume":"5","author":"E Ozkumur","year":"2013","unstructured":"Ozkumur E, Shah AM, Ciciliano JC, Emmink BL, Miyamoto DT, Brachtel E, et al. Inertial focusing for tumor antigen-dependent and -independent sorting of rare circulating tumor cells. Sci Transl Med. 2013;5(179):179ra47-ra47.","journal-title":"Sci Transl Med"},{"issue":"4","key":"4120_CR116","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/s41416-018-0186-7","volume":"119","author":"I Krol","year":"2018","unstructured":"Krol I, Castro-Giner F, Maurer M, Gkountela S, Szczerba BM, Scherrer R, et al. Detection of circulating tumour cell clusters in human glioblastoma. Br J Cancer. 2018;119(4):487\u201391.","journal-title":"Br J Cancer"},{"issue":"43","key":"4120_CR117","doi-asserted-by":"publisher","first-page":"36757","DOI":"10.1021\/acsami.8b14632","volume":"10","author":"AC Soares","year":"2018","unstructured":"Soares AC, Soares JC, Rodrigues VC, Follmann HDM, Arantes LMRB, Carvalho AC, et al. Microfluidic-based genosensor to detect human papillomavirus (HPV16) for head and neck cancer. ACS Appl Mater Interfaces. 2018;10(43):36757\u201363.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"3","key":"4120_CR118","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41416-021-01626-0","volume":"126","author":"V Mishra","year":"2022","unstructured":"Mishra V, Singh A, Chen X, Rosenberg AJ, Pearson AT, Zhavoronkov A, et al. Application of liquid biopsy as multi-functional biomarkers in head and neck cancer. Br J Cancer. 2022;126(3):361\u201370.","journal-title":"Br J Cancer"},{"issue":"14","key":"4120_CR119","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2217\/bmm-2020-0022","volume":"14","author":"Y Meng","year":"2020","unstructured":"Meng Y, Bian L, Zhang M, Bo F, Lu X, Li D. Liquid biopsy and their application progress in head and neck cancer: focus on biomarkers CTCs, cfDNA, ctDNA and EVs. Biomark Med. 2020;14(14):1393\u2013404.","journal-title":"Biomark Med"},{"issue":"14","key":"4120_CR120","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.1021\/ac301392g","volume":"84","author":"R Malhotra","year":"2012","unstructured":"Malhotra R, Patel V, Chikkaveeraiah BV, Munge BS, Cheong SC, Zain RB, et al. Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. Anal Chem. 2012;84(14):6249\u201355.","journal-title":"Anal Chem"},{"issue":"1","key":"4120_CR121","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13027-025-00641-7","volume":"20","author":"Y Huang","year":"2025","unstructured":"Huang Y, Wang J, Yang W, Hou F, Feng X. Precision therapeutic targets for HPV-positive cancers: an overview and new insights. Infect Agents Cancer. 2025;20(1):17.","journal-title":"Infect Agents Cancer"},{"issue":"35","key":"4120_CR122","doi-asserted-by":"publisher","first-page":"29598","DOI":"10.1039\/C6RA01456A","volume":"6","author":"D Jin","year":"2016","unstructured":"Jin D, Ma X, Luo Y, Fang S, Xie Z, Li X, et al. Application of a microfluidic-based perivascular tumor model for testing drug sensitivity in head and neck cancers and toxicity in endothelium. RSC Adv. 2016;6(35):29598\u2013607.","journal-title":"RSC Adv"},{"issue":"2","key":"4120_CR123","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1053\/j.sult.2022.02.003","volume":"43","author":"E Avery","year":"2022","unstructured":"Avery E, Sanelli PC, Aboian M, Payabvash S. Radiomics: a primer on processing workflow and analysis. Semin Ultrasound CT MR. 2022;43(2):142\u20136. https:\/\/doi.org\/10.1053\/j.sult.2022.02.003.","journal-title":"Semin Ultrasound CT MR"},{"issue":"3","key":"4120_CR124","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00405-023-08380-4","volume":"281","author":"TC Wu","year":"2024","unstructured":"Wu TC, Liu YL, Chen JH, Chen TY, Ko CC, Lin CY, et al. Radiomics analysis for the prediction of locoregional recurrence of locally advanced oropharyngeal cancer and hypopharyngeal cancer. Eur Arch Otorhinolaryngol. 2024;281(3):1473\u201381.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"4120_CR125","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109684","volume":"184","author":"Z Pan","year":"2023","unstructured":"Pan Z, Men K, Liang B, Song Z, Wu R, Dai J. A subregion-based prediction model for local-regional recurrence risk in head and neck squamous cell carcinoma. Radiother Oncol. 2023;184:109684. https:\/\/doi.org\/10.1016\/j.radonc.2023.109684.","journal-title":"Radiother Oncol"},{"issue":"7","key":"4120_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237048","volume":"15","author":"S Keek","year":"2020","unstructured":"Keek S, Sanduleanu S, Wesseling F, de Reinout R, van den Michiel B, van der Heijden M, et al. Correction: Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy. PLoS ONE. 2020;15(7):e0237048.","journal-title":"PLoS ONE"},{"issue":"3","key":"4120_CR127","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3348\/kjr.2019.0025","volume":"20","author":"DW Kim","year":"2019","unstructured":"Kim DW, Jang HY, Kim KW, Shin Y, Park SH. Design characteristics of studies reporting the performance of artificial intelligence algorithms for diagnostic analysis of medical images: results from recently published papers. Korean J Radiol. 2019;20(3):405\u201310.","journal-title":"Korean J Radiol"},{"issue":"1","key":"4120_CR128","doi-asserted-by":"publisher","first-page":"42517","DOI":"10.1038\/srep42517","volume":"7","author":"A Kulasinghe","year":"2017","unstructured":"Kulasinghe A, Tran THP, Blick T, O\u2019Byrne K, Thompson EW, Warkiani ME, et al. Enrichment of circulating head and neck tumour cells using spiral microfluidic technology. Sci Rep. 2017;7(1):42517.","journal-title":"Sci Rep"},{"key":"4120_CR129","doi-asserted-by":"crossref","unstructured":"Mannino MC, Kerr CP, Schehr JL, Zhao SG, Morris ZS, Lang JM. Microfluidic characterization of circulating tumor cells from mouse models and patients with head and neck cancer. Cancer Res. 2022;82(12_Supplement):5121.","DOI":"10.1158\/1538-7445.AM2022-5121"},{"issue":"5","key":"4120_CR130","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/elsc.202100133","volume":"22","author":"J Stiefel","year":"2022","unstructured":"Stiefel J, Freese C, Sriram A, Alebrand S, Srinivas N, Sproll C, et al. Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients. Eng Life Sci. 2022;22(5):391\u2013406.","journal-title":"Eng Life Sci"},{"key":"4120_CR131","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071778","author":"SP Haider","year":"2020","unstructured":"Haider SP, Zeevi T, Baumeister P, Reichel C, Sharaf K, Forghani R, et al. Potential added value of PET\/CT radiomics for survival prognostication beyond AJCC 8th edition staging in oropharyngeal squamous cell carcinoma. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12071778.","journal-title":"Cancers (Basel)"},{"key":"4120_CR132","doi-asserted-by":"crossref","unstructured":"Singh A, Sahu A, Verma S. Computer intelligence in detection of malignant or premalignant oral lesions: the story so far. 2022. p. 187\u2013200.","DOI":"10.1007\/978-981-16-9221-5_11"},{"issue":"3","key":"4120_CR133","doi-asserted-by":"publisher","DOI":"10.1002\/cnr2.2045","volume":"7","author":"SM Jayawickrama","year":"2024","unstructured":"Jayawickrama SM, Ranaweera PM, Pradeep R, Jayasinghe YA, Senevirathna K, Hilmi AJ, et al. Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments. Cancer Rep. 2024;7(3):e2045. https:\/\/doi.org\/10.1002\/cnr2.2045.","journal-title":"Cancer Rep"},{"key":"4120_CR134","doi-asserted-by":"publisher","DOI":"10.1063\/1.5100009","author":"H Gwak","year":"2019","unstructured":"Gwak H, Kim J, Cha S, Cheon YP, Kim S-I, Kwak B, et al. On-chip isolation and enrichment of circulating cell-free DNA using microfluidic device. Biomicrofluidics. 2019. https:\/\/doi.org\/10.1063\/1.5100009.","journal-title":"Biomicrofluidics"},{"issue":"7","key":"4120_CR135","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15071959","volume":"15","author":"NF Saba","year":"2023","unstructured":"Saba NF, Pamulapati S, Patel B, Mody M, Strojan P, Takes R, et al. Novel immunotherapeutic approaches to treating HPV-related head and neck cancer. Cancers. 2023;15(7):1959. https:\/\/doi.org\/10.3390\/cancers15071959.","journal-title":"Cancers"},{"issue":"3","key":"4120_CR136","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1158\/2326-6066.CIR-17-0299","volume":"6","author":"B Solomon","year":"2018","unstructured":"Solomon B, Young RJ, Bressel M, Urban D, Hendry S, Thai A, et al. Prognostic significance of PD-L1+ and CD8+ immune cells in HPV+ oropharyngeal squamous cell carcinoma. Cancer Immunol Res. 2018;6(3):295\u2013304.","journal-title":"Cancer Immunol Res"},{"issue":"17","key":"4120_CR137","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.89829","volume":"1","author":"R Mandal","year":"2016","unstructured":"Mandal R, \u015eenbabao\u011flu Y, Desrichard A, Havel JJ, Dalin MG, Riaz N, et al. The head and neck cancer immune landscape and its immunotherapeutic implications. JCI Insight. 2016;1(17):e89829. https:\/\/doi.org\/10.1172\/jci.insight.89829.","journal-title":"JCI Insight"},{"issue":"35","key":"4120_CR138","doi-asserted-by":"publisher","first-page":"56781","DOI":"10.18632\/oncotarget.10788","volume":"7","author":"O Wood","year":"2016","unstructured":"Wood O, Woo J, Seumois G, Savelyeva N, McCann KJ, Singh D, et al. Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors. Oncotarget. 2016;7(35):56781.","journal-title":"Oncotarget"},{"issue":"9","key":"4120_CR139","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1002\/ijc.29962","volume":"138","author":"S Wagner","year":"2016","unstructured":"Wagner S, Wittekindt C, Reuschenbach M, Hennig B, Thevarajah M, W\u00fcrdemann N, et al. CD 56\u2010positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma. Int J Cancer. 2016;138(9):2263\u201373. https:\/\/doi.org\/10.1002\/ijc.29962.","journal-title":"Int J Cancer"},{"key":"4120_CR140","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15061642","author":"K Starska-Kowarska","year":"2023","unstructured":"Starska-Kowarska K. The role of different immunocompetent cell populations in the pathogenesis of head and neck cancer-regulatory mechanisms of pro- and anti-cancer activity and their impact on immunotherapy. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15061642.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"4120_CR141","doi-asserted-by":"publisher","first-page":"17684","DOI":"10.18632\/oncotarget.15179","volume":"8","author":"TJ Nulton","year":"2017","unstructured":"Nulton TJ, Olex AL, Dozmorov M, Morgan IM, Windle B. Analysis of the Cancer Genome Atlas sequencing data reveals novel properties of the human papillomavirus 16 genome in head and neck squamous cell carcinoma. Oncotarget. 2017;8(11):17684.","journal-title":"Oncotarget"},{"issue":"12","key":"4120_CR142","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1016\/j.oraloncology.2013.09.009","volume":"49","author":"N Gildener-Leapman","year":"2013","unstructured":"Gildener-Leapman N, Ferris RL, Bauman JE. Promising systemic immunotherapies in head and neck squamous cell carcinoma. Oral Oncol. 2013;49(12):1089\u201396.","journal-title":"Oral Oncol"},{"key":"4120_CR143","unstructured":"Grinnell M, Krishnan M, Ganti AK. HPV and the immune system in head and neck cancers: therapeutic considerations. Oncology (Williston Park). 2020;34(4):693630."},{"key":"4120_CR144","doi-asserted-by":"publisher","first-page":"1450830","DOI":"10.3389\/fonc.2024.1450830","volume":"14","author":"X-Y Liu","year":"2024","unstructured":"Liu X-Y, Shang-Guan H-J, Zhang W, Chen S, Luo X-Y. Efficacy of PD-1 inhibitor with neoadjuvant chemotherapy in hypopharyngeal and oropharyngeal cancer. Front Oncol. 2024;14:1450830.","journal-title":"Front Oncol"},{"key":"4120_CR145","doi-asserted-by":"publisher","first-page":"1189752","DOI":"10.3389\/fimmu.2023.1189752","volume":"14","author":"K Wang","year":"2023","unstructured":"Wang K, Gui L, Lu H, He X, Li D, Liu C, et al. Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas. Front Immunol. 2023;14:1189752.","journal-title":"Front Immunol"},{"issue":"19","key":"4120_CR146","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","volume":"375","author":"RL Ferris","year":"2016","unstructured":"Ferris RL, Blumenschein G Jr, Fayette J, Guigay J, Colevas AD, Licitra L, et al. Nivolumab for recurrent squamous-cell carcinoma of the head and neck. N Engl J Med. 2016;375(19):1856\u201367.","journal-title":"N Engl J Med"},{"issue":"4","key":"4120_CR147","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.3390\/jcm14041170","volume":"14","author":"DM Filippini","year":"2025","unstructured":"Filippini DM, Broseghini E, Liberale C, Gallerani G, Siepe G, Nobili E, et al. Vaccine-based immunotherapy for oropharyngeal and nasopharyngeal cancers. J Clin Med. 2025;14(4):1170.","journal-title":"J Clin Med"},{"issue":"9","key":"4120_CR148","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012555","volume":"13","author":"C Even","year":"2025","unstructured":"Even C, Harrington KJ, Massarelli E, Laban S, Fayette J, Oliva M, et al. Randomized clinical efficacy and safety study of peltopepimut-S plus cemiplimab compared to cemiplimab alone in patients with recurrent\/metastatic HPV16-positive head and neck cancer. J Immunother Cancer. 2025;13(9):e012555. https:\/\/doi.org\/10.1136\/jitc-2025-012555.","journal-title":"J Immunother Cancer"},{"key":"4120_CR149","doi-asserted-by":"crossref","unstructured":"Strauss J, Floudas CS, Sater HA, Manu M, Lamping E, Francis DC, et al. Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies. J Clin Oncol. 2021;39(15_suppl):2501.","DOI":"10.1200\/JCO.2021.39.15_suppl.2501"},{"key":"4120_CR150","doi-asserted-by":"crossref","unstructured":"Nishio S. Bintrafusp alfa and its unsuccessful development journey towards cervical cancer treatment. Taylor & Francis; 2025. p. 1\u20133.","DOI":"10.1080\/14712598.2025.2541795"},{"issue":"2","key":"4120_CR151","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001395","volume":"8","author":"J Strauss","year":"2020","unstructured":"Strauss J, Gatti-Mays ME, Cho BC, Hill A, Salas S, McClay E, et al. Bintrafusp alfa, a bifunctional fusion protein targeting TGF-\u03b2 and PD-L1, in patients with human papillomavirus-associated malignancies. J Immunother Cancer. 2020;8(2):e001395. https:\/\/doi.org\/10.1136\/jitc-2020-001395.","journal-title":"J Immunother Cancer"},{"issue":"13","key":"4120_CR152","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1177\/15353702221089910","volume":"247","author":"SR Gameiro","year":"2022","unstructured":"Gameiro SR, Strauss J, Gulley JL, Schlom J. Preclinical and clinical studies of bintrafusp alfa, a novel bifunctional anti-PD-L1\/TGF\u03b2RII agent: current status. Exp Biol Med. 2022;247(13):1124\u201334. https:\/\/doi.org\/10.1177\/15353702221089910.","journal-title":"Exp Biol Med"},{"issue":"2","key":"4120_CR153","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000664","volume":"8","author":"BC Cho","year":"2020","unstructured":"Cho BC, Daste A, Ravaud A, Salas S, Isambert N, McClay E, et al. Bintrafusp alfa, a bifunctional fusion protein targeting TGF-\u03b2 and PD-L1, in advanced squamous cell carcinoma of the head and neck: results from a phase I cohort. J Immunother Cancer. 2020;8(2):e000664. https:\/\/doi.org\/10.1136\/jitc-2020-000664.","journal-title":"J Immunother Cancer"},{"key":"4120_CR154","doi-asserted-by":"crossref","unstructured":"Zhang Z, Meng X, Han L. Application and perspectives of immunotherapy in head and neck squamous cell carcinoma. Immunology. 2024;176(2):164-178. https:\/\/doi.org\/10.1111\/imm.13951.","DOI":"10.1111\/imm.13951"},{"key":"4120_CR155","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22656","author":"D Wusiman","year":"2023","unstructured":"Wusiman D, Li W, Guo L, Huang Z, Zhang Y, Zhang X, et al. Comprehensive analysis of single-cell and bulk RNA-sequencing data identifies B cell marker genes signature that predicts prognosis and analysis of immune checkpoints expression in head and neck squamous cell carcinoma. Heliyon. 2023. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22656.","journal-title":"Heliyon"},{"issue":"8","key":"4120_CR156","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1002\/ijc.33446","volume":"148","author":"A von Witzleben","year":"2021","unstructured":"von Witzleben A, Fehn A, Grages A, Ezi\u0107 J, Jeske SS, Puntigam LK, et al. Prospective longitudinal study of immune checkpoint molecule (ICM) expression in immune cell subsets during curative conventional therapy of head and neck squamous cell carcinoma (HNSCC). Int J Cancer. 2021;148(8):2023\u201335.","journal-title":"Int J Cancer"},{"key":"4120_CR157","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.oraloncology.2016.04.005","volume":"57","author":"Y Kondo","year":"2016","unstructured":"Kondo Y, Ohno T, Nishii N, Harada K, Yagita H, Azuma M. Differential contribution of three immune checkpoint (VISTA, CTLA-4, PD-1) pathways to antitumor responses against squamous cell carcinoma. Oral Oncol. 2016;57:54\u201360.","journal-title":"Oral Oncol"},{"issue":"4","key":"4120_CR158","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s00262-024-03643-3","volume":"73","author":"TY Seiwert","year":"2024","unstructured":"Seiwert TY, Wildsmith S, Fayette J, Harrington K, Gillison M, Ahn M-J, et al. Outcomes in biomarker-selected subgroups from the KESTREL study of durvalumab and tremelimumab in recurrent or metastatic head and neck squamous cell carcinoma. Cancer Immunol Immunother. 2024;73(4):70.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"4120_CR159","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41368-020-0084-8","volume":"12","author":"Z Mei","year":"2020","unstructured":"Mei Z, Huang J, Qiao B, Lam AK-y. Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma. Int J Oral Sci. 2020;12(1):16.","journal-title":"Int J Oral Sci"},{"key":"4120_CR160","doi-asserted-by":"publisher","DOI":"10.1080\/03639045.2025.2552392","author":"B Almutairy","year":"2025","unstructured":"Almutairy B, Alharthi S, Ebrahimi Shahmabadi H, Alavi SE. Use of nanoemulsion for co-delivery of silibinin and cabazitaxel for prostate cancer treatment. Drug Dev Ind Pharm. 2025. https:\/\/doi.org\/10.1080\/03639045.2025.2552392.","journal-title":"Drug Dev Ind Pharm"},{"issue":"8","key":"4120_CR161","doi-asserted-by":"publisher","DOI":"10.1007\/s13205-025-04443-x","volume":"15","author":"SE Alavi","year":"2025","unstructured":"Alavi SE, Ebrahimi Shahmabadi H, Sharma LA, Sharma A. Nanoparticle-based drug delivery systems for non-surgical periodontal therapy: innovations and clinical applications. 3 Biotech. 2025;15(8):269.","journal-title":"3 Biotech"},{"key":"4120_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2025.107306","author":"B Almutairy","year":"2025","unstructured":"Almutairy B, Alharthi S, Shahmabadi HE, Alavi SE. Using nanostructured lipid carrier for the co-delivery of rifampicin and pentamidine for the treatment of cutaneous leishmaniasis. J Drug Deliv Sci Technol. 2025. https:\/\/doi.org\/10.1016\/j.jddst.2025.107306.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"9","key":"4120_CR163","doi-asserted-by":"publisher","first-page":"5255","DOI":"10.3390\/curroncol31090389","volume":"31","author":"TD Pham","year":"2024","unstructured":"Pham TD, Teh M-T, Chatzopoulou D, Holmes S, Coulthard P. Artificial intelligence in head and neck cancer: innovations, applications, and future directions. Curr Oncol. 2024;31(9):5255\u201390.","journal-title":"Curr Oncol"},{"issue":"11","key":"4120_CR164","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.767","volume":"5","author":"C Sorrentino","year":"2024","unstructured":"Sorrentino C, Ciummo SL, Fieni C, Di Carlo E. Nanomedicine for cancer patient\u2010centered care. MedComm. 2024;5(11):e767. https:\/\/doi.org\/10.1002\/mco2.767.","journal-title":"MedComm"},{"issue":"12","key":"4120_CR165","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123466","volume":"13","author":"P Garg","year":"2024","unstructured":"Garg P, Pareek S, Kulkarni P, Salgia R, Singhal SS. Nanoengineering solutions for cancer therapy: bridging the gap between clinical practice and translational research. J Clin Med. 2024;13(12):3466. https:\/\/doi.org\/10.3390\/jcm13123466.","journal-title":"J Clin Med"},{"key":"4120_CR166","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-025-01698-8","author":"E-M Froicu","year":"2025","unstructured":"Froicu E-M, Creang\u0103-Murariu I, Afr\u0103s\u00e2nie V-A, Gafton B, Alexa-Stratulat T, Miron L, et al. Artificial intelligence and decision-making in oncology: a review of ethical, legal, and informed consent challenges. Curr Oncol Rep. 2025. https:\/\/doi.org\/10.1007\/s11912-025-01698-8.","journal-title":"Curr Oncol Rep"},{"key":"4120_CR167","doi-asserted-by":"crossref","unstructured":"Alavi SE, Sharma LA, Sharma A, Ebrahimi Shahmabadi H. Salivary biomarkers in periodontal disease: revolutionizing early detection and precision dentistry. Mol Diagn Ther. 2025;29(6):721-740. https:\/\/doi.org\/10.1007\/s40291-025-00799-1.","DOI":"10.1007\/s40291-025-00799-1"},{"issue":"22","key":"4120_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12226962","volume":"12","author":"SE Alavi","year":"2023","unstructured":"Alavi SE, Gholami M, Shahmabadi HE, Reher P. Resorbable GBR scaffolds in oral and maxillofacial tissue engineering: design, fabrication, and applications. J Clin Med. 2023;12(22):6962. https:\/\/doi.org\/10.3390\/jcm12226962.","journal-title":"J Clin Med"},{"issue":"3","key":"4120_CR169","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s12194-017-0406-5","volume":"10","author":"K Suzuki","year":"2017","unstructured":"Suzuki K. Overview of deep learning in medical imaging. Radiol Phys Technol. 2017;10(3):257\u201373. https:\/\/doi.org\/10.1007\/s12194-017-0406-5.","journal-title":"Radiol Phys Technol"},{"key":"4120_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2024.100591","author":"VP Veeraraghavan","year":"2024","unstructured":"Veeraraghavan VP, Daniel S, Dasari AK, Aileni KR, Patil SR. Harnessing artificial intelligence for predictive modelling in oral oncology: opportunities, challenges, and clinical perspectives. Oral Oncol Rep. 2024. https:\/\/doi.org\/10.1016\/j.oor.2024.100591.","journal-title":"Oral Oncol Rep"},{"issue":"6","key":"4120_CR171","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061291","volume":"13","author":"S Camalan","year":"2021","unstructured":"Camalan S, Mahmood H, Binol H, Araujo ALD, Santos-Silva AR, Vargas PA, et al. Convolutional neural network-based clinical predictors of oral dysplasia: class activation map analysis of deep learning results. Cancers. 2021;13(6):1291. https:\/\/doi.org\/10.3390\/cancers13061291.","journal-title":"Cancers"},{"issue":"1","key":"4120_CR172","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34025-x","volume":"13","author":"JM Dolezal","year":"2022","unstructured":"Dolezal JM, Srisuwananukorn A, Karpeyev D, Ramesh S, Kochanny S, Cody B, et al. Uncertainty-informed deep learning models enable high-confidence predictions for digital histopathology. Nat Commun. 2022;13(1):6572. https:\/\/doi.org\/10.1038\/s41467-022-34025-x.","journal-title":"Nat Commun"},{"issue":"1","key":"4120_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-023-00399-4","volume":"7","author":"JM Dolezal","year":"2023","unstructured":"Dolezal JM, Wolk R, Hieromnimon HM, Howard FM, Srisuwananukorn A, Karpeyev D, et al. Deep learning generates synthetic cancer histology for explainability and education. NPJ Precis Oncol. 2023;7(1):49. https:\/\/doi.org\/10.1038\/s41698-023-00399-4.","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"4120_CR174","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","volume":"11","author":"JE Van Timmeren","year":"2020","unstructured":"Van Timmeren JE, Cester D, Tanadini-Lang S, Alkadhi H, Baessler B. Radiomics in medical imaging\u2014\u201chow-to\u201d guide and critical reflection. Insights Imaging. 2020;11(1):91.","journal-title":"Insights Imaging"},{"issue":"7","key":"4120_CR175","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-048008","volume":"11","author":"GS Collins","year":"2021","unstructured":"Collins GS, Dhiman P, Navarro CLA, Ma J, Hooft L, Reitsma JB, et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open. 2021;11(7):e048008. https:\/\/doi.org\/10.1136\/bmjopen-2020-048008.","journal-title":"BMJ Open"},{"key":"4120_CR176","unstructured":"Navarro CLA, Damen JA, Hooft L, Reitsma JB, van Smeden M, Riley RD, et al. Protocol for development of a risk of bias assessment tool for diagnostic and prognositc prediction studies based on artificial intelligence: PROBAST-AI. In: Navarro CLA, editor. Quality of machine learning prediction models in healthcare. The Netherlands: Ridderprint; 2024. pp. 222-235."},{"key":"4120_CR177","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2024.110196","volume":"194","author":"C Hurkmans","year":"2024","unstructured":"Hurkmans C, Bibault J-E, Clementel E, Dhont J, van Elmpt W, Kantidakis G, et al. Assessment of bias in scoring of AI-based radiotherapy segmentation and planning studies using modified TRIPOD and PROBAST guidelines as an example. Radiother Oncol. 2024;194:110196. https:\/\/doi.org\/10.1016\/j.radonc.2024.110196.","journal-title":"Radiother Oncol"},{"issue":"4","key":"4120_CR178","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1007\/s44230-023-00041-3","volume":"3","author":"A Yaqoob","year":"2023","unstructured":"Yaqoob A, Musheer Aziz R, Verma NK. Applications and techniques of machine learning in cancer classification: a systematic review. Human-centric intelligent systems. 2023;3(4):588\u2013615.","journal-title":"Human-centric intelligent systems"},{"issue":"4","key":"4120_CR179","doi-asserted-by":"publisher","first-page":"71","DOI":"10.21037\/atm.2019.11.121","volume":"8","author":"L Chen","year":"2020","unstructured":"Chen L. Overview of clinical prediction models. Ann Transl Med. 2020;8(4):71.","journal-title":"Ann Transl Med"},{"issue":"6","key":"4120_CR180","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3390\/biomedicines11061612","volume":"11","author":"SB Khanagar","year":"2023","unstructured":"Khanagar SB, Alkadi L, Alghilan MA, Kalagi S, Awawdeh M, Bijai LK, et al. Application and performance of artificial intelligence (AI) in oral cancer diagnosis and prediction using histopathological images: a systematic review. Biomedicines. 2023;11(6):1612.","journal-title":"Biomedicines"},{"issue":"22","key":"4120_CR181","doi-asserted-by":"publisher","first-page":"3461","DOI":"10.3390\/diagnostics13223461","volume":"13","author":"B Nagarajan","year":"2023","unstructured":"Nagarajan B, Chakravarthy S, Venkatesan VK, Ramakrishna MT, Khan SB, Basheer S, et al. A deep learning framework with an intermediate layer using the swarm intelligence optimizer for diagnosing oral squamous cell carcinoma. Diagnostics. 2023;13(22):3461.","journal-title":"Diagnostics"},{"issue":"14","key":"4120_CR182","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.3390\/cancers15143608","volume":"15","author":"X Jiang","year":"2023","unstructured":"Jiang X, Hu Z, Wang S, Zhang Y. Deep learning for medical image-based cancer diagnosis. Cancers. 2023;15(14):3608.","journal-title":"Cancers"},{"issue":"4","key":"4120_CR183","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095364","volume":"9","author":"T Yasui","year":"2014","unstructured":"Yasui T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, et al. Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS ONE. 2014;9(4):e95364. https:\/\/doi.org\/10.1371\/journal.pone.0095364.","journal-title":"PLoS ONE"},{"issue":"1","key":"4120_CR184","volume":"2022","author":"K Ramezani","year":"2022","unstructured":"Ramezani K, Tofangchiha M. Oral cancer screening by artificial intelligence\u2010oriented interpretation of optical coherence tomography images. Radiol Res Pract. 2022;2022(1):1614838.","journal-title":"Radiol Res Pract"},{"issue":"14","key":"4120_CR185","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.3390\/diagnostics13142416","volume":"13","author":"V Pereira-Prado","year":"2023","unstructured":"Pereira-Prado V, Martins-Silveira F, Sicco E, Hochmann J, Isiordia-Espinoza MA, Gonz\u00e1lez RG, et al. Artificial intelligence for image analysis in oral squamous cell carcinoma: a review. Diagnostics. 2023;13(14):2416.","journal-title":"Diagnostics"},{"issue":"7","key":"4120_CR186","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11274-025-04427-2","volume":"41","author":"B Almutairy","year":"2025","unstructured":"Almutairy B, Alharthi S, Ebrahimi Shahmabadi H, Alavi SE. Optimized solid lipid nanoparticles for co-delivery of gentamicin and doxycycline: a novel approach to combat intracellular brucella abortus infections. World J Microbiol Biotechnol. 2025;41(7):1\u201315.","journal-title":"World J Microbiol Biotechnol"},{"issue":"5","key":"4120_CR187","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12032-025-02714-4","volume":"42","author":"S Alharthi","year":"2025","unstructured":"Alharthi S, Alrashidi AA, Ziora Z, Ebrahimi Shahmabadi H, Alavi SE. Innovative PEGylated chitosan nanocarriers for co-delivery of doxorubicin and CpG in breast cancer therapy: preparation, characterization, and immunotherapeutic potential. Med Oncol. 2025;42(5):1\u201319.","journal-title":"Med Oncol"},{"issue":"3","key":"4120_CR188","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/03639045.2025.2463395","volume":"51","author":"S Alharthi","year":"2025","unstructured":"Alharthi S, Alrashidi AA, Almawash S, Ebrahimi Shahmabadi H, Alavi SE. Targeted antibacterial and anticancer therapeutics: PEGylated liposomal delivery of turmeric and cinnamon extracts-in vitro and in vivo efficacy. Drug Dev Ind Pharm. 2025;51(3):231\u201343.","journal-title":"Drug Dev Ind Pharm"},{"key":"4120_CR189","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2025.1566522","volume":"13","author":"J-J Zhou","year":"2025","unstructured":"Zhou J-J, Feng Y-C, Zhao M-L, Guo Q, Zhao X-B. Nanotechnology in the perioperative treatment of head and neck cancer: application and outlook. Front Bioeng Biotechnol. 2025;13:1566522. https:\/\/doi.org\/10.3389\/fbioe.2025.1566522.","journal-title":"Front Bioeng Biotechnol"},{"issue":"17","key":"4120_CR190","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1016\/j.biomaterials.2013.02.012","volume":"34","author":"J-H Wang","year":"2013","unstructured":"Wang J-H, Wang B, Liu Q, Li Q, Huang H, Song L, et al. Bimodal optical diagnostics of oral cancer based on Rose Bengal conjugated gold nanorod platform. Biomaterials. 2013;34(17):4274\u201383. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.02.012.","journal-title":"Biomaterials"},{"key":"4120_CR191","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102327","volume":"32","author":"N Muhanna","year":"2021","unstructured":"Muhanna N, Eu D, Chan HH, Daly M, Fricke IB, Douglas CM, et al. Assessment of a liposomal CT\/optical contrast agent for image-guided head and neck surgery. Nanomedicine Nanotechnol Biol Med. 2021;32:102327.","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"issue":"2","key":"4120_CR192","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-025-02603-w","volume":"42","author":"H Alyami","year":"2025","unstructured":"Alyami H, Alharthi S, Alqahtani AJ, Ebrahimi Shahmabadi H, Alavi SE. Enhanced antitumor efficacy of nanostructured lipid carrier co-loaded with docetaxel and 5-fluorouracil for targeted gastric cancer therapy. Med Oncol. 2025;42(2):53. https:\/\/doi.org\/10.1007\/s12032-025-02603-w.","journal-title":"Med Oncol"},{"issue":"6","key":"4120_CR193","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s40005-024-00691-w","volume":"54","author":"SE Alavi","year":"2024","unstructured":"Alavi SE, Alavi SF, Koohi M, Raza A, Ebrahimi Shahmabadi H. Nanoparticle-integrated metal\u2013organic frameworks: a revolution in next-generation drug delivery systems. J Pharm Investig. 2024;54(6):751\u201383. https:\/\/doi.org\/10.1007\/s40005-024-00691-w.","journal-title":"J Pharm Investig"},{"key":"4120_CR194","doi-asserted-by":"crossref","unstructured":"Alharthi S, Alavi SZ, Nisa Mu, Koohi M, Raza A, Ebrahimi Shahmabadi H, et al. Developing engineered nano-immunopotentiators for the stimulation of dendritic cells and inhibition and prevention of melanoma. Pharm Res. 2024;41(6):1163\u201381.","DOI":"10.1007\/s11095-024-03722-1"},{"issue":"4","key":"4120_CR195","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1021\/acs.bioconjchem.1c00091","volume":"32","author":"SE Alavi","year":"2021","unstructured":"Alavi SE, Cabot PJ, Raza A, Moyle PM. Developing GLP-1 conjugated self-assembling nanofibers using copper-catalyzed alkyne\u2013azide cycloaddition and evaluation of their biological activity. Bioconjug Chem. 2021;32(4):810\u201320.","journal-title":"Bioconjug Chem"},{"issue":"7","key":"4120_CR196","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1021\/acs.bioconjchem.0c00291","volume":"31","author":"SE Alavi","year":"2020","unstructured":"Alavi SE, Cabot PJ, Yap GY, Moyle PM. Optimized methods for the production and bioconjugation of site-specific, alkyne-modified glucagon-like peptide-1 (GLP-1) analogs to azide-modified delivery platforms using copper-catalyzed alkyne\u2013azide cycloaddition. Bioconjug Chem. 2020;31(7):1820\u201334.","journal-title":"Bioconjug Chem"},{"issue":"6","key":"4120_CR197","doi-asserted-by":"publisher","first-page":"2278","DOI":"10.1021\/acs.molpharmaceut.9b00308","volume":"16","author":"SE Alavi","year":"2019","unstructured":"Alavi SE, Cabot PJ, Moyle PM. Glucagon-like peptide-1 receptor agonists and strategies to improve their efficiency. Mol Pharm. 2019;16(6):2278\u201395.","journal-title":"Mol Pharm"},{"key":"4120_CR198","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jconrel.2021.07.034","volume":"337","author":"L Kampel","year":"2021","unstructured":"Kampel L, Goldsmith M, Ramishetti S, Veiga N, Rosenblum D, Gutkin A, et al. Therapeutic inhibitory RNA in head and neck cancer via functional targeted lipid nanoparticles. J Control Release. 2021;337:378\u201389.","journal-title":"J Control Release"},{"issue":"4","key":"4120_CR199","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.vaccine.2020.11.049","volume":"39","author":"M Tomljenovic","year":"2021","unstructured":"Tomljenovic M, Petrovic G, Antoljak N, Hansen L. Vaccination attitudes, beliefs and behaviours among primary health care workers in northern Croatia. Vaccine. 2021;39(4):738\u201345.","journal-title":"Vaccine"},{"key":"4120_CR200","doi-asserted-by":"crossref","unstructured":"Sullivan R, Pramesh CS. Politics of Cancer. In: Giuliani M, Gospodarowicz MK, Brierley JD, Sullivan R, Giannopoulos E, Tittenbrun Z, editors. Cancer Systems and Control for Health Professionals. Hoboken: John Wiley & Sons, Ltd; 2025. pp. 3\u20139. https:\/\/doi.org\/10.1002\/9781394191369.ch1.1.","DOI":"10.1002\/9781394191369.ch1.1"},{"issue":"4","key":"4120_CR201","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41591-022-01738-x","volume":"28","author":"C Pramesh","year":"2022","unstructured":"Pramesh C, Badwe RA, Bhoo-Pathy N, Booth CM, Chinnaswamy G, Dare AJ, et al. Priorities for cancer research in low-and middle-income countries: a global perspective. Nat Med. 2022;28(4):649\u201357.","journal-title":"Nat Med"},{"issue":"10","key":"4120_CR202","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/jnci\/djad123","volume":"115","author":"EC Dee","year":"2023","unstructured":"Dee EC, Eala MAB, Robredo JPG, Ramiah D, Hubbard A, Ho FDV, et al. Leveraging national and global political determinants of health to promote equity in cancer care. JNCI J Natl Cancer Inst. 2023;115(10):1157\u201363.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"3","key":"4120_CR203","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/ijerph22030439","volume":"22","author":"MS Lipsky","year":"2025","unstructured":"Lipsky MS, Wolfe G, Radilla BA, Hung M. Human Papillomavirus: a narrative review for dental providers in prevention and care. Int J Environ Res Public Health. 2025;22(3):439.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4120_CR204","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10865-022-00342-1","volume":"46","author":"ML Kornides","year":"2023","unstructured":"Kornides ML, Badlis S, Head KJ, Putt M, Cappella J, Gonzalez-Hernadez G. Exploring content of misinformation about HPV vaccine on twitter. J Behav Med. 2023;46(1):239\u201352. https:\/\/doi.org\/10.1007\/s10865-022-00342-1.","journal-title":"J Behav Med"},{"issue":"10","key":"4120_CR205","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/ijgc-2022-003685","volume":"32","author":"N Taumberger","year":"2022","unstructured":"Taumberger N, Joura EA, Arbyn M, Kyrgiou M, Sehouli J, Gultekin M. Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO prevention committee. Int J Gynecol Cancer. 2022;32(10):1316\u201320. https:\/\/doi.org\/10.1136\/ijgc-2022-003685.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"4120_CR206","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.adaj.2022.09.014","volume":"154","author":"SM Casey","year":"2023","unstructured":"Casey SM, Paiva T, Perkins RB, Villa A, Murray EJ. Could oral health care professionals help increase human papillomavirus vaccination rates by engaging patients in discussions? J Am Dent Assoc. 2023;154(1):10-23. e17.","journal-title":"J Am Dent Assoc"},{"issue":"4","key":"4120_CR207","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16040703","volume":"16","author":"A Meci","year":"2024","unstructured":"Meci A, Goyal N, Slonimsky G. Mechanisms of resistance and therapeutic perspectives in immunotherapy for advanced head and neck cancers. Cancers. 2024;16(4):703. https:\/\/doi.org\/10.3390\/cancers16040703.","journal-title":"Cancers"},{"key":"4120_CR208","doi-asserted-by":"crossref","unstructured":"Rischin D, Harrington KJ, Greil R, Soulieres D, Tahara M, de Castro Jr G, et al. Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048. Oral Oncol. 2022;128:105815.","DOI":"10.1016\/j.oraloncology.2022.105815"},{"issue":"2","key":"4120_CR209","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1093\/jnci\/djaa063","volume":"113","author":"KJ Harrington","year":"2021","unstructured":"Harrington KJ, Souli\u00e8res D, Le Tourneau C, Dinis J, Licitra LF, Ahn M-J, et al. Quality of life with pembrolizumab for recurrent and\/or metastatic head and neck squamous cell carcinoma: KEYNOTE-040. JNCI J Natl Cancer Inst. 2021;113(2):171\u201381.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"16","key":"4120_CR210","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1158\/1078-0432.CCR-21-4554","volume":"28","author":"JL Leddon","year":"2022","unstructured":"Leddon JL, Gulati S, Haque S, Allen C, Palackdharry S, Mathews M, et al. Phase II trial of adjuvant nivolumab following salvage resection in patients with recurrent squamous cell carcinoma of the head and neck. Clin Cancer Res. 2022;28(16):3464\u201372. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-4554.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"4120_CR211","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12553-023-00738-2","volume":"13","author":"S Askin","year":"2023","unstructured":"Askin S, Burkhalter D, Calado G, El Dakrouni S. Artificial intelligence applied to clinical trials: opportunities and challenges. Health Technol. 2023;13(2):203\u201313. https:\/\/doi.org\/10.1007\/s12553-023-00738-2.","journal-title":"Health Technol"},{"issue":"6","key":"4120_CR212","doi-asserted-by":"publisher","DOI":"10.3390\/ph18060788","volume":"18","author":"V Malheiro","year":"2025","unstructured":"Malheiro V, Santos B, Figueiras A, Mascarenhas-Melo F. The potential of artificial intelligence in pharmaceutical innovation: from drug discovery to clinical trials. Pharmaceuticals. 2025;18(6):788. https:\/\/doi.org\/10.3390\/ph18060788.","journal-title":"Pharmaceuticals"},{"key":"4120_CR213","doi-asserted-by":"crossref","unstructured":"Gupta D, Wal P, Wal A, KR S, Kumar M, Panda KC, et al. AI in clinical trials and drug development: challenges and potential and advancements. Curr Drug Disc Technol. 2024;22(4):E15701638314252. https:\/\/doi.org\/10.2174\/0115701638314252241016165345.","DOI":"10.2174\/0115701638314252241016165345"},{"issue":"1","key":"4120_CR214","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","volume":"31","author":"K Zhang","year":"2025","unstructured":"Zhang K, Yang X, Wang Y, Yu Y, Huang N, Li G, et al. Artificial intelligence in drug development. Nat Med. 2025;31(1):45\u201359.","journal-title":"Nat Med"},{"issue":"7536","key":"4120_CR215","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nature14129","volume":"517","author":"CGA Network","year":"2015","unstructured":"Network CGA. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015;517(7536):576.","journal-title":"Nature"},{"issue":"19","key":"4120_CR216","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMcp2108502","volume":"388","author":"LE Markowitz","year":"2023","unstructured":"Markowitz LE, Unger ER. Human papillomavirus vaccination. N Engl J Med. 2023;388(19):1790\u20138.","journal-title":"N Engl J Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04120-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-025-04120-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-025-04120-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T11:02:20Z","timestamp":1776769340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-025-04120-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":216,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4120"],"URL":"https:\/\/doi.org\/10.1007\/s12094-025-04120-8","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}